|
WAPAL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.561100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.397400E-04 |
| Normal-vs-Stage2 |
2.395800E-01 |
| Normal-vs-Stage3 |
7.639700E-02 |
| Normal-vs-Stage4 |
1.040600E-01 |
| Stage1-vs-Stage2 |
4.180000E-01 |
| Stage1-vs-Stage3 |
6.209000E-01 |
| Stage1-vs-Stage4 |
6.852200E-01 |
| Stage2-vs-Stage3 |
7.433800E-01 |
| Stage2-vs-Stage4 |
8.473400E-01 |
| Stage3-vs-Stage4 |
9.369200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.396700E-04 |
| Normal-vs-AfricanAmerican |
3.600300E-02 |
| Normal-vs-Asian |
1.064160E-01 |
| Caucasian-vs-AfricanAmerican |
5.865200E-01 |
| Caucasian-vs-Asian |
9.358400E-01 |
| AfricanAmerican-vs-Asian |
9.131400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.01380000000629E-05 |
| Normal-vs-Female |
4.078400E-01 |
| Male-vs-Female |
2.520400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.562700E-03 |
| Normal-vs-Extreme_Weight |
3.65190000000126E-05 |
| Normal-vs-Obese |
1.492760E-01 |
| Normal-vs-Extreme_Obese |
3.538500E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.456400E-01 |
| Normal_Weight-vs-Obese |
1.495170E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.198600E-01 |
| Extreme_Weight-vs-Obese |
2.246400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.975400E-01 |
| Obese-vs-Extreme_Obese |
2.066600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.772000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.273900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.26949999999815E-05 |
| Normal-vs-Age(81-100Yrs) |
2.579800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.735600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.395700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.439700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.496100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.192300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.582360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.555000E-03 |
| Normal-VS-Type2 PRCC |
1.77473999999345E-05 |
| Normal-VS-KIRP CIMP |
7.948400E-01 |
| Normal-VS-Unclassified PRCC |
4.074600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.140400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.806600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.861400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.379800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.331800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.346400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97316999999142E-05 |
| Normal-vs-N1 |
6.539400E-01 |
| Normal-vs-N2 |
1.735660E-03 |
| N0-vs-N1 |
6.881300E-03 |
| N0-vs-N2 |
4.642600E-01 |
| N1-vs-N2 |
7.152300E-02 |
|
|
